|
|||||
![]() |
|
American firearms manufacturer Smith & Wesson (NASDAQ:SWBI) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 3.7% year on year to $85.08 million. Its non-GAAP loss of $0.08 per share was 33.3% above analysts’ consensus estimates.
Is now the time to buy SWBI? Find out in our full research report (it’s free).
Smith & Wesson’s Q2 results for 2025 reflected a mixed picture, as the company’s revenue surpassed Wall Street’s expectations despite a year-over-year decline. Management highlighted robust demand for new products, particularly in the handgun segment, which saw shipments rise over 35% in the sporting goods channel. CEO Mark Peter Smith credited the strength of the Bodyguard, Shield, and M&P lines for driving these results. However, he acknowledged that the overall market remained highly promotional and that average selling prices trended lower. Smith noted, “Our performance during the seasonal slow period for firearms demonstrates the strength of our brand and the ongoing success of our innovation strategy.”
Looking ahead, management expects typical seasonal strength in the second half of the year but remains cautious due to ongoing macroeconomic headwinds and tariff impacts. The company plans to maintain a disciplined approach to promotions while focusing on expanding its product lineup and leveraging the recent reopening of the Smith & Wesson Academy. CFO Deana McPherson stated that gross margins are likely to remain under pressure from tariffs and lower production absorption, and operating expenses will rise with higher volume and special initiatives. Management believes that its innovation pipeline and clean inventory position will allow Smith & Wesson to maintain or expand market share going forward.
Management attributed the quarter’s performance to new product success in handguns, selective participation in promotions, and effective inventory management, while also highlighting external pressures on pricing and margins.
Smith & Wesson’s outlook centers on expanding its product portfolio, navigating tariffs, and adjusting promotional strategies to protect both market share and profitability.
Looking forward, our analysts will watch for (1) the pace of new product launches and their acceptance in the market, (2) the company’s ability to maintain or improve average selling prices in a promotional environment, and (3) the impact of steel tariffs and higher operating expenses on margins. Progress on the relaunch of the Smith & Wesson Academy and regulatory changes affecting suppressors will also be key indicators of execution.
Smith & Wesson currently trades at $8.25, in line with $8.22 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Sep-11 | |
Sep-11 | |
Sep-08 | |
Sep-05 | |
Sep-05 | |
Sep-05 | |
Sep-05 | |
Sep-04 | |
Sep-04 | |
Sep-04 | |
Sep-02 | |
Sep-02 | |
Aug-21 | |
Aug-15 | |
Aug-01 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite